AI in Drug Discovery Market Growth and Status Explored in a New Research Report 2035
Date of Publication: 29 May 2025 - Roots Analysis has published its latest report titled ‘‘AI in Drug Discovery Market, offering an in-depth overview of the global landscape. This study provides a historical perspective and a future outlook for the market, analyzing trends and growth patterns from 2025 to 2035. The report explores how the market size has evolved and identifies the major forces shaping its direction in the coming years.
The AI in drug discovery market size is estimated to grow from USD 1.8 billion in 2024 to reach USD 2.9 billion in 2025 and USD 13.4 billion by 2035, representing a higher CAGR of 16.5% during the forecast period. This projected growth is supported by steady expansion across multiple regions and consistent adoption across key crop types. The report refrains from speculative assumptions, offering fact-based analysis of market shifts and potential opportunities.
Source of Information- https://www.rootsanalysis.com/reports/ai-based-drug-discovery-market.html
The research includes a clear breakdown of business activities, competitive strategies, and investment initiatives. It outlines the position of top companies in ‘AI in Drug Discovery and discusses their strategic moves in the global space. Their financial performance, product ranges, and operational footprints are presented to support understanding of the competitive structure within the ‘AI in Drug Discovery Market.
Distribution by DrugDiscovery Steps
Target identification / validation
Hit generation / lead identification
Lead optimization
Distribution by TherapeuticArea
Oncological disorders
CNS disorders
Infectious diseases
Respiratory disorders
Cardiovascular disorders
Endocrine disorders
Gastrointestinal disorders
Musculoskeletal disorders
Immunological disorders
Dermatological disorders
Others
Key Geographical Region
North America
Europe
Asia-Pacific
Latin America
Middle East and North Africa
Rest of the World
Key Companies Profiled
Aiforia Technologies
Atomwise
BioSyntagma
Chemalive
Collaborations Pharmaceuticals
Cyclica
DeepMatter
Recursion
InveniAI
MAbSilico
Optibrium
Recursion Pharmaceuticals
Sensyne Health
Valo Health
The geographical scope of the study covers Aiforia Technologies, Atomwise, BioSyntagma, Chemalive, Collaborations Pharmaceuticals, Cyclica, DeepMatter, Recursion, InveniAI, MAbSilico, Optibrium, Recursion Pharmaceuticals, Sensyne Health, Valo Health. Each region is examined with respect to current demand, accessibility of products, and regional developments. These geographic insights contribute to a deeper understanding of the global ‘AI in Drug Discovery Market share and help identify performance differences between developed and emerging markets.
The report features profiles of key players operating in the ‘AI in Drug Discovery sector, including Aiforia Technologies, Atomwise, BioSyntagma, Chemalive, Collaborations Pharmaceuticals, Cyclica, DeepMatter, Recursion, InveniAI, MAbSilico, Optibrium, Recursion Pharmaceuticals, Sensyne Health, Valo Health. These company profiles provide a snapshot of their business strategy, market presence, and major contributions to the ‘AI in Drug Discovery Market.
The study further discusses market performance across various regions, product categories, and other segments. It presents a factual evaluation of the ‘AI in Drug Discovery industry share and reviews the regulatory and operational dynamics influencing global adoption. The report emphasizes consistency and clarity in presenting the forecast model and expected market trajectory.
Readers are also presented with analysis on corporate strategies including mergers and acquisitions, regional partnerships, and joint ventures. These strategies are reviewed in the context of historical data and current execution trends, offering an informed overview of ‘AI in Drug Discovery Market growth potential.
The report highlights the impact of external conditions such as pricing changes, investment flow, and emerging business models. It avoids speculation and focuses on available insights that can guide real-world business decisions. Coverage includes major areas of interest for companies exploring new opportunities in the market for ‘AI in Drug Discovery.
Research Methodology This study is backed by structured primary and secondary research methodologies. Roots Analysis used a range of reliable sources including company disclosures, government records, and expert interviews. The research framework supports accurate and transparent analysis, allowing businesses to derive actionable insights from the ‘AI in Drug Discovery Market forecast.
For more information or to request a personalized version of this report, please contact our team at sales@rootsanalysis.com. We are happy to support your specific business objectives with customized research solutions.
About Roots Analysis
Roots Analysis is a global leader in market research, competitive intelligence and consulting services across industries. The leading market research company – Roots Analysis has different product offerings. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, and venture and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. All reports provided by us are structured in a way that enables the reader to develop a thorough perspective on the given subject. Apart from writing reports on identified areas, we provide bespoke research / consulting services dedicated to serving our clients in the best possible way.
Contact Details
Roots Analysis
Gaurav Chaudhary
+1 (857) 387 7999 +44 (748) 188 1310
Gaurav.chaudhary@rootsanalysis.com
Website: https://www.rootsanalysis.com/